Exact Sciences cites cancer screening study

Exact Sciences Corp. today pointed to a new study that indicates that many consumers prefer the method of colorectal screening for cancer that Exact Sciences is exploring.

The Marlborough company, which uses applied genomics to develop screening technologies for cancer detection, is working on stool-based DNA testing of colorectal cancer.

The study that Exact Sciences pointed to appears in the July issue of The American Journal of Managed Care, the company said.

According to Exact Sciences, the study concluded that patients who are educated about, but inexperienced with, the various colorectal cancer screening methods prefer stool-based DNA technology over other non-invasive methods.